Reply to: "Hepatic benefits of HCV cure: Don't forget coagulation!"
- PMID: 33345830
- DOI: 10.1016/j.jhep.2020.12.015
Reply to: "Hepatic benefits of HCV cure: Don't forget coagulation!"
Conflict of interest statement
Conflicts of interest Vincenza Calvaruso: Travel Grant, Speaking, and Participation to Advisory Boards for: AbbVie, Gilead Sciences and Intercept. Grant and research support: MSD. Antonio Craxì: Research grants, lecturing fees, advisory boards, scientific consultancy for Abbvie, Gilead Sciences, BMS, MSD, Intercept. Please refer to the accompanying ICMJE disclosure forms for further details.
Comment on
-
Hepatic benefits of HCV cure.J Hepatol. 2020 Dec;73(6):1548-1556. doi: 10.1016/j.jhep.2020.08.006. Epub 2020 Aug 7. J Hepatol. 2020. PMID: 32777323 Review.
-
SARS-CoV-2 massive testing: A window of opportunity to catch up with HCV elimination.J Hepatol. 2021 Apr;74(4):966-967. doi: 10.1016/j.jhep.2020.10.001. Epub 2020 Oct 9. J Hepatol. 2021. PMID: 33039405 Free PMC article. No abstract available.
-
Hepatic benefits of HCV cure: Don't forget coagulation!J Hepatol. 2021 Apr;74(4):967-968. doi: 10.1016/j.jhep.2020.10.031. Epub 2020 Dec 16. J Hepatol. 2021. PMID: 33340585 No abstract available.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical